THE BEST THERAPY FOR HELICOBACTER-PYLORI INFECTION - SHOULD EFFICACY OR SIDE-EFFECT PROFILE DETERMINE OUR CHOICE

被引：103
作者：
DEBOER, WA [1 ]
TYTGAT, GNJ [1 ]
机构：
[1] UNIV AMSTERDAM,ACAD MED CTR,DEPT GASTROENTEROL,1105 AZ AMSTERDAM,NETHERLANDS
来源：
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 1995年 / 30卷 / 05期
关键词：
D O I：
10.3109/00365529509093298
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：401 / 407
页数：7
相关论文
共 61 条
[1]  
ATHERTON JC, 1994, GASTROENTEROLOGY, V106, pA42
[2]  
ATHERTON JC, 1994, GASTROENTEROLOGY, V106, pA41
[3]  
BALATSOS V, 1993, GASTROENTEROLOGY, V104, pA37
[4]  
BAYERDORFFER E, 1992, EUR J GASTROEN HEPAT, V4, P697
[5]  
BAYERDORFFER E, 1994, GASTROENTEROLOGY, V106, pA48
[6]   SHORT-TERM LOW-DOSE TRIPLE THERAPY FOR THE ERADICATION OF HELICOBACTER-PYLORI [J].
BAZZOLI, F ;
ZAGARI, RM ;
FOSSI, S ;
POZZATO, P ;
ALAMPI, G ;
SIMONI, P ;
SOTTILI, S ;
RODA, A ;
RODA, E .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 (09) :773-777
[7]   METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI [J].
BECX, MCJM ;
JANSSEN, AJHM ;
CLASENER, HAL ;
DEKONING, RW .
LANCET, 1990, 335 (8688) :539-540
[8]  
BELL GD, 1992, ALIMENT PHARM THERAP, V6, P427
[9]  
BELL GD, 1992, ALIMENT PHARM THERAP, V6, P751
[10]  
BELL GD, 1991, EUR J GASTROEN HEPAT, P923
1234567